# Cefiderocol in the Treatment of Multidrug-resistant Gram-negative Bacilli Infections, a Retrospective Study

> **NCT05544682** · — · UNKNOWN · sponsor: **University Hospital, Strasbourg, France** · enrollment: 15 (estimated)

## Conditions studied

- Multidrug Resistant Bacterial Infection

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05544682
- **Lead sponsor:** University Hospital, Strasbourg, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-01
- **Primary completion:** 2023-12
- **Final completion:** 2023-12
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2023-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05544682

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05544682, "Cefiderocol in the Treatment of Multidrug-resistant Gram-negative Bacilli Infections, a Retrospective Study". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05544682. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*